Tech Company Financing Transactions
Aldexa Therapeutics Funding Round
Domain Associates and Johnson & Johnson Development Corporation participated in a $9 million Series A funding round for Aldexa Therapeutics. The funding round closed on 8/8/2008.
Transaction Overview
Company Name
Announced On
8/8/2008
Transaction Type
Venture Equity
Amount
$8,960,000
Round
Series A
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
15 New England Executive Park
Burlington, MA 01803
USA
Burlington, MA 01803
USA
Phone
Website
Email Address
Not Recorded
Overview
Aldexa Therapeutics was founded in 2012 based on the insight that aldehydes are pivotal upstream mediators of major medical diseases. The ability to capture and remove aldehydes from causing toxic damage has the potential to treat a number of diseases as well as prevent disease progression.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Todd Brady
Chief Operating Officer
Scott Young
Browse more venture capital transactions:
Prev: 8/8/2008: The Vehicle Production Group venture capital transaction
Next: 8/8/2008: ChosenSecurity venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on funding rounds that are announced publicly. VC investment data records on this site are sourced from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs